Cancer Patients Develop ‘Adequate’ Immune Response to COVID Vax
May 28, 2021 11:09 amIn a prospective study in Israel, 90% of cancer patients were seropositive for antibodies
By Mike Bassett
The vast majority of patients undergoing active systemic therapy for cancer exhibited an adequate immune response to the Pfizer/BioNTech COVID-19 vaccine, according to … Read more